Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,07 CNY | -1,10 % | -5,06 % | -27,03 % |
Resumen de negocios
Número de empleados: 1 878
Ventas por actividad
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Crack, Small Crack
58,6
%
| 529 | 50,2 % | 728 | 58,6 % | +37,63 % |
Other Pharmaceutical Products
14,5
%
| 126 | 12,0 % | 180 | 14,5 % | +42,27 % |
OEM and Wholesale and Retail Drugs
12,3
%
| 138 | 13,1 % | 152 | 12,3 % | +10,82 % |
Complete Production Line
7,9
%
| 176 | 16,7 % | 98 | 7,9 % | -44,66 % |
Property Leasing and Management
3,4
%
| 46 | 4,3 % | 42 | 3,4 % | -8,32 % |
Health Care Product
2,1
%
| 26 | 2,5 % | 27 | 2,1 % | +1,83 % |
Mechanical Parts and Others
0,9
%
| 9 | 0,8 % | 11 | 0,9 % | +31,85 % |
Vertical Circulating Stereo Parking Equipment
0,4
%
| 4 | 0,4 % | 5 | 0,4 % | +28,34 % |
Ventas por región
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
China
99,1
%
| 1 049 | 99,6 % | 1 231 | 99,1 % | +17,34 % |
Overseas
0,9
%
| 5 | 0,4 % | 12 | 0,9 % | +158,15 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 09/12/19 |
Qing Guo Wang
DFI | Director of Finance/CFO | 49 | 25/08/22 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 13/10/17 |
Qiang Lin
BRD | Director/Board Member | 60 | 01/07/04 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 01/07/04 |
Xin He
IRC | Investor Relations Contact | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jin Lou
BRD | Director/Board Member | 94 | 13/10/17 |
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 09/12/19 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 01/07/04 |
Run Xiu Li
BRD | Director/Board Member | 55 | 01/07/04 |
Jian Wei Zhu
BRD | Director/Board Member | 69 | 18/11/20 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 13/10/17 |
Wen Jie Ma
BRD | Director/Board Member | 42 | 13/10/17 |
Liu Yang
BRD | Director/Board Member | 39 | 13/10/17 |
Li Li Wang
BRD | Director/Board Member | 47 | 13/10/17 |
Sheng Xuan Jin
BRD | Director/Board Member | 48 | 26/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 401 743 872 | 156 631 424 ( 38,99 %) | 0 | 38,99 % |
Información de la empresa
Sichuan Goldstone Asia Pharmaceutical, Inc.
8/F, Area A1 Dadi New Guanghua Plaza
610072, Chengdu
+
http://www.goldstone-group.comSector
Ventas por actividad
Ventas por región
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-27,03 % | 453 M | |
+20,91 % | 43,54 mil M | |
+16,96 % | 21,74 mil M | |
+9,05 % | 13,53 mil M | |
+7,98 % | 13,02 mil M | |
+33,80 % | 11,28 mil M | |
-11,05 % | 6992,75 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+6,64 % | 5093,73 M |
- Bolsa de valores
- Acciones
- Acción 300434
- Empresa Sichuan Goldstone Asia Pharmaceutical Inc.